Clinical trial
The Vascutek Rapidax™ II Post Market Surveillance Registry
NCT01977508 is registered in ClinicalTrials.gov with Vascutek Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Vascutek Rapidax™ II Post Market Surveillance Registry
- Lead sponsor
- Vascutek Ltd.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 31, 2013
- Completion date
- May 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
end stage kidney disease